FDA Staff Reductions Raise Concerns Over Medication Safety and Agency Morale

Inspectors at the FDA report that recent staff cuts and layoffs have significantly hampered their ability to effectively monitor and inspect foreign drug manufacturing facilities, potentially compromising drug safety for millions of Americans. Despite official statements claiming inspections continue unaffected, experienced personnel have been lost, and support staff reductions have slowed investigations, raising concerns about the oversight of overseas drug production.